Back
Minerva Neurosciences Stock Predictions
Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
39
NERV
Minerva Neurosciences
Last Price:
$1.51
Seasonality Move:
11.64%
7 Day Trial
ALL ACCESS PASS
$
7
Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with NasdaqMinerva Neurosciences Stock Forecast
-
Is Minerva Neurosciences Stock Undervalued?The current Minerva Neurosciences [NERV] share price is $1.50. The Score for NERV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
NERV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Minerva Neurosciences Stock Go Up Next Year?
Data Unavailable
Minerva Neurosciences Stock Rating
Data Unavailable
Minerva Neurosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
minervaneurosciences.com
52-Week Data
52-Week High:
3.69
52-Week Low:
1.15
Prediction Charts
Market Cap:
10.5M
Price in USD:
1.50
Volume:
8.9K
Beta:
0.61
Technical Analysis
SMA50:
1.60
SMA100:
1.81
SMA200:
2.16
52-Wk Change:
-37.6%
Stock Predictions
-
Is Minerva Neurosciences stock public?Yes, Minerva Neurosciences is a publicly traded company.
-
What is the Minerva Neurosciences stock quote today?The Minerva Neurosciences stock price is 1.50 USD today.
-
How to buy Minerva Neurosciences stock online?You can buy Minerva Neurosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-9 | 1.59 | 1.61 | 1.69 | 1.59 |
| May-12 | 1.68 | 1.63 | 1.74 | 1.59 |
| May-13 | 1.66 | 1.63 | 1.72 | 1.63 |
| May-14 | 1.70 | 1.54 | 1.70 | 1.52 |
| May-15 | 1.59 | 1.56 | 1.65 | 1.52 |
| May-16 | 1.53 | 1.50 | 1.57 | 1.50 |
| May-19 | 1.48 | 1.45 | 1.60 | 1.43 |
| May-20 | 1.44 | 1.38 | 1.44 | 1.30 |
| May-21 | 1.39 | 1.45 | 1.58 | 1.39 |
| May-22 | 1.48 | 1.45 | 1.58 | 1.41 |
| May-23 | 1.42 | 1.46 | 1.48 | 1.42 |
| May-27 | 1.50 | 1.49 | 1.50 | 1.35 |
| May-28 | 1.50 | 1.54 | 1.55 | 1.50 |
| May-29 | 1.52 | 1.50 | 1.54 | 1.48 |
Minerva Neurosciences Earnings
Data Unavailable
Minerva Neurosciences Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.38 per share, and an increase next year of $0.80 per share.
* Minerva Neurosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.